Patents by Inventor Yoon Suk Lee

Yoon Suk Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250333747
    Abstract: Disclosed are a synthetic nucleic acid molecule including 5?-UTR with improved translation efficiency and a vaccine/therapeutic composition including the same, and more particularly, a 5?-UTR polynucleotide that is imparted with improved translation efficiency based on the specific motif thereof, a synthetic nucleic acid molecule including the same and a vaccine/therapeutic composition including the synthetic nucleic acid molecule. The 5?-UTR polynucleotide effectively induces expression of target proteins due to improved translation efficiency thereof and thus is useful for various RNA-based applications, for example, vaccines, in vivo/ex vivo gene therapy, etc.
    Type: Application
    Filed: December 2, 2022
    Publication date: October 30, 2025
    Inventors: Min-Kyung SHIN, Hongseok HA, Joori PARK, Sena LEE, Yoon Ki KIM, Jaesung JUNG, Yoon Suk LEE, Hyokyoung KWON, Tae-Hee KIM, Yeomin YUN
  • Publication number: 20100159616
    Abstract: A bio-chip has a base plate, and a fluid resin layer positioned on the base plate and having a plurality of convexo-concave structures that are uniformly arranged in line. Side walls of the structures form reflecting films to form a Fabry-Perot interferometer structure. The bio-chip is used to detect an analyte provided to the bio-chip, so that it is possible to rapidly analyze the small amount of samples and to realize the detection sensitivity relatively higher than the conventional method.
    Type: Application
    Filed: April 16, 2007
    Publication date: June 24, 2010
    Applicant: KOREA TECHNOLOGY INDUSTRY CO., LTD.
    Inventors: Kwan Han Park, Kang Hoon Lee, Byong Chon Jon, Moon Hi Han, Yoon Suk Lee
  • Patent number: 6884882
    Abstract: A 2?-deoxyuridine derivative of formula I is bioavailable and thermally stable and forms a gel in water at a low concentration; and, can be employed as a drug delivery vehicle:
    Type: Grant
    Filed: April 27, 2004
    Date of Patent: April 26, 2005
    Assignee: Postech Foundation
    Inventors: Byeang Hyean Kim, Sun Min Park, Yoon Suk Lee